Abstract:Background Growing evidence indicates that dynamic changes in the gut microbiome can affect intelligence; however, whether the relationships are causal is unknown. Methods We conducted a bidirectional two-sample Mendelian randomization (MR) analysis using the summary statistics from the largest GWAS meta-analysis of gut microbiota composition (n = 18,340) and intelligence (n = 269,867). Inverse-variance weighted method was used to conduct the MR analyses complemented by a range of sensitivity analyses to validate the robustness of the results. We further applied a two-step MR analysis to evaluate whether the effect of identified taxa on intelligence was mediated by regulating the brain volume. Results MR evidence suggested a risk effect of the genus Oxalobacter on intelligence (β = –0.032; 95% confidence interval, –0.049 to –0.015; P = 1.88 ×10-4) and a protective effect of the genus Fusicatenibacter on intelligence (β = 0.051; 95% confidence interval, 0.023 to 0.079; P = 3.03× 10-4). In the other direction, we did not find causal evidence of intelligence on gut microbiome composition. The mediation analysis showed that the effect of genus Fusicatenibacter on intelligence was partly mediated by regulating the brain volume, with a mediated proportion of 26.7% (95% confidence interval, 4.9% to 48.5%). Conclusions Our findings may help reshape our understanding of the microbiota-gut-brain axis and development of novel intervention approaches for preventing cognitive impairment. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This study is supported by the National Natural Science Foundation of China (82101601, 32170616), the Natural Science Basic Research Program of Shaanxi Province (2021JC-02), China Postdoctoral Science Foundation (2023T160517, 2021M702612, 2020M683454, 2021T140546), and the special guidance funds for the construction of world-class universities (disciplines) and characteristic development in central universities. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study used ONLY openly available human data that were originally located at: ; [https://ctg.cncr.nl/software/summary_statistics/][1] I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data produced in the present work are contained in the manuscript [1]: https://ctg.cncr.nl/software/summary_statistics/s

Sex Specific Effect of Gut Microbiota on the Risk of Psychiatric Disorders: A Mendelian Randomisation Study and PRS Analysis Using UK Biobank Cohort

Causal effects of gut microbiota on the risk of bipolar disorder: a Mendelian randomization study

Gut Microbiota and Psychiatric Disorders: A Two-Sample Mendelian Randomization Study

Evaluating the genetic interaction effects of gut microbiome and diet on the risk of neuroticism in the UK Biobank cohort

Assessing the Joint Effects of Brain Aging and Gut Microbiota on the Risks of Psychiatric Disorders

Evaluating the Genetic Effects of Gut Microbiota on the Development of Neuroticism and General Happiness: A Polygenic Score Analysis and Interaction Study Using UK Biobank Data

Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study

The causal association between gut microbiota and postpartum depression: a two-sample Mendelian randomization study

Gut microbiota and postpartum depression: a Mendelian randomization study

Association between gut microbiota and postpartum depression: A bidirectional Mendelian randomization study

Causal effect of the gut microbiota on the risk of psychiatric disorders and the mediating role of immunophenotypes

Causal relationships between gut microbiota and depression/anxiety disorders: A 2-sample Mendelian randomization study.

Female genital prolapse and risk of psychiatric disorders: A two-sample Mendelian randomization analysis

Gut microbiota and cognitive performance: A bidirectional two-sample Mendelian randomization

Mendelian Randomization Analyses Identify Causal Associations of Human Gut Microbiome Composition on Intelligence

Improving precision management of anxiety disorders: a Mendelian randomization study targeting specific gut microbiota and associated metabolites

Gut microbiome and major depressive disorder: insights from two-sample Mendelian randomization

Assessing the Effect of Interaction Between C-Reactive Protein and Gut Microbiome on the Risks of Anxiety and Depression

Associations between gut microbiota and Alzheimer’s disease, major depressive disorder, and schizophrenia

The interactions between host genome and gut microbiome increase the risk of psychiatric disorders: Mendelian randomization and biological annotation

Anorexia nervosa and bulimia nervosa: a Mendelian randomization study of gut microbiota